SCHEDULE 13G/A

Kura Oncology Inc

Common Stock, par value $0.0001 per share · CUSIP: 50127T109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• BIOTECHNOLOGY VALUE FUND L P

  Shares: 1,751,852.00 · Class: 2.2%

• BVF I GP LLC

  Shares: 1,751,852.00 · Class: 2.2%

• BIOTECHNOLOGY VALUE FUND II LP

  Shares: 1,410,347.00 · Class: 1.8%

• BVF II GP LLC

  Shares: 1,410,347.00 · Class: 1.8%

• Biotechnology Value Trading Fund OS LP

  Shares: 177,882.00 · Class: 0.2%

• BVF Partners OS Ltd.

  Shares: 177,882.00 · Class: 0.2%

• BVF GP HOLDINGS LLC

  Shares: 3,162,199.00 · Class: 4.0%

• BVF PARTNERS L P/IL

  Shares: 3,408,054.00 · Class: 4.3%

• BVF INC/IL

  Shares: 3,408,054.00 · Class: 4.3%

• LAMPERT MARK N

  Shares: 3,408,054.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.